Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

BAY 11-7085

NF-κB inhibitor
BML-EI279-0010 10 mg 113.00 USD
BML-EI279-0050 50 mg 462.00 USD
Do you need bulk/larger quantities?
Replaces Prod. #: ALX-270-220

An irreversible inhibitor of cytokine-inducible IκBα phosphorylation (IC50=10 µM). In intact HUVECs it inhibits TNFα-induced phosphorylation and degradation of IκBα without affecting constitutive phosphorylation. Inhibition of IκBα phosphorylation and degradation results in the inactivation of NF-κB and NF-κB-dependent expression of endothelial-leukocyte adhesion molecules, E-selectin, VCAM-1 and ICAM-1. BAY 11-7085 displayed potent anti-inflammatory activity in the rat carrageenan paw edema assay and adjuvant arthritis model.

Product Details

Purity:≥99% (TLC)
Appearance:White solid.
Solubility:Soluble in DMSO (>25mg/ml) or 100% ethanol (>25mg/ml). Insoluble in water.
Shipping:Ambient Temperature
Long Term Storage:Ambient
Handling:Protect from light. Keep under inert gas.
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis: L.C. Chang, et al.; Cancer Lett. 416, 124 (2018), Abstract;
Drug-perturbation-based stratification of blood cancer: S. Dietrich, et al.; J. Clin. Invest. 128, 427 (2017), Abstract; Full Text
Phosphoinositide 3-kinase-δ regulates fungus-induced allergic lung inflammation through endoplasmic reticulum stress: K.S. Lee, et al.; Thorax 71, 52 (2015), Application(s): Cell culture , Abstract; Full Text
TGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling Mechanisms: W.B. Fang, et al.; PLoS One 10, e0135063 (2015), Abstract; Full Text
In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas: P.A. Robe, et al.; Clin. Cancer Res. 10, 5595 (2004), Abstract;
Neuronal injury-induced expression and release of apolipoprotein E in mixed neuron/glia co-cultures: nuclear factor kappaB inhibitors reduce basal and lesion-induced secretion of apolipoprotein E: V. Petegnief, et al.; Neuroscience 104, 223 (2001), Abstract;
Pharmacologic interference with NF-kappaB activation attenuates central nervous system complications in experimental Pneumococcal meningitis: U. Koedel, et al.; J. Infect. Dis. 182, 1437 (2000), Abstract;
Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo: J.W. Pierce, et al.; J. Biol. Chem. 272, 21096 (1997), Abstract;